| P50 | author | Erika Isolauri | Q23039746 |
| | Catherine Stanton | Q56605088 |
| P2093 | author name string | Jürgen Schrezenmeir | |
| | Glenn R Gibson | |
| | Lorenzo Morelli | |
| | Herbert Lochs | |
| | Ian R Rowland | |
| | Kristin Verbeke | |
| | Robert J Brummer | |
| | Theo Ockhuizen | |
| P2860 | cites work | Systematic review and meta-analysis of Saccharomyces boulardii in adult patients | Q24621081 |
| | Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells | Q28169032 |
| | Stool form scale as a useful guide to intestinal transit time | Q28249217 |
| | Probiotics for prevention of antibiotic-associated diarrhea | Q28283304 |
| | Meta-analysis of probiotics for the prevention of traveler's diarrhea | Q28288124 |
| | The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health? | Q28302385 |
| | News from the Cochrane Library: probiotics for the prevention of paediatric antibiotic-associated diarrhoea | Q33294301 |
| | Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data | Q33546633 |
| | Probiotics-host communication: Modulation of signaling pathways in the intestine | Q34018028 |
| | Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis | Q34094620 |
| | Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants | Q34165056 |
| | Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling | Q34621850 |
| | Probiotics: a novel approach in the management of food allergy | Q34738168 |
| | Bias in dietary-report instruments and its implications for nutritional epidemiology | Q35084175 |
| | Validation of a specific quality of life questionnaire for functional digestive disorders | Q35354662 |
| | Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease | Q37185074 |
| | Validation of a short form Wisconsin Upper Respiratory Symptom Survey (WURSS-21). | Q37356135 |
| | Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans | Q37481930 |
| | What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease? | Q37759115 |
| | Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis | Q40094968 |
| | Selection of methodology to assess food intake | Q42679011 |
| | Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier | Q43132701 |
| | Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors. | Q43786165 |
| | Scientific Opinion on the substantiation of a health claim related Immunofortis® and strengthening of the baby's immune system pursuant to Article 14 of Regulation (EC) No 1924/2006 | Q47147882 |
| | Guidance on the scientific requirements for health claims related to gut and immune function | Q47149591 |
| | Health claims substantiation for probiotic and prebiotic products. | Q51165151 |
| | An Irritable Bowel Syndrome-Specific Symptom Questionnaire: Development and Validation | Q53370277 |
| | Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. | Q54415037 |
| | Mechanisms of action of probiotics in intestinal diseases. | Q55177013 |
| | Probiotic and prebiotic claims in Europe: seeking a clear roadmap | Q57241154 |
| | Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial | Q57569167 |
| P433 | issue | 5 | |
| P921 | main subject | probiotics | Q1816730 |
| P304 | page(s) | 299-305 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | Gut microbes | Q26841922 |
| P1476 | title | The design of probiotic studies to substantiate health claims. | |
| P478 | volume | 2 | |